WO2003004524A3 - Apicomplexa parasites secreted proteins - Google Patents
Apicomplexa parasites secreted proteins Download PDFInfo
- Publication number
- WO2003004524A3 WO2003004524A3 PCT/GB2002/003045 GB0203045W WO03004524A3 WO 2003004524 A3 WO2003004524 A3 WO 2003004524A3 GB 0203045 W GB0203045 W GB 0203045W WO 03004524 A3 WO03004524 A3 WO 03004524A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- secreted proteins
- apicomplexa
- parasites
- apicomplexa parasites
- vaccines
- Prior art date
Links
- 241000224482 Apicomplexa Species 0.000 title abstract 2
- 244000045947 parasite Species 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002317946A AU2002317946A1 (en) | 2001-07-02 | 2002-07-02 | Apicomplexa parasites secreted proteins |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0116185.0A GB0116185D0 (en) | 2001-07-02 | 2001-07-02 | Substances |
GB0116185.0 | 2001-07-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003004524A2 WO2003004524A2 (en) | 2003-01-16 |
WO2003004524A3 true WO2003004524A3 (en) | 2003-07-10 |
Family
ID=9917808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2002/003045 WO2003004524A2 (en) | 2001-07-02 | 2002-07-02 | Apicomplexa parasites secreted proteins |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002317946A1 (en) |
GB (1) | GB0116185D0 (en) |
WO (1) | WO2003004524A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022162588A1 (en) * | 2021-01-28 | 2022-08-04 | Cambridge Enterprise Limited | Method of treatment of malaria by targetting open reading frames |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000063241A2 (en) * | 1999-04-15 | 2000-10-26 | Children's Medical Center Corporation | Methods and compositions for modulating an immune response |
-
2001
- 2001-07-02 GB GBGB0116185.0A patent/GB0116185D0/en not_active Ceased
-
2002
- 2002-07-02 AU AU2002317946A patent/AU2002317946A1/en not_active Abandoned
- 2002-07-02 WO PCT/GB2002/003045 patent/WO2003004524A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000063241A2 (en) * | 1999-04-15 | 2000-10-26 | Children's Medical Center Corporation | Methods and compositions for modulating an immune response |
Non-Patent Citations (2)
Title |
---|
DATABASE EMBL [online] EBI; 19 February 2001 (2001-02-19), FISHER ET AL.: "Human osteopontin.", XP002239709, Database accession no. AAB19770 * |
OCKENHOUSE CHRISTIAN F ET AL: "Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum Malaria.", JOURNAL OF INFECTIOUS DISEASES, vol. 177, no. 6, June 1998 (1998-06-01), pages 1664 - 1673, XP008016615, ISSN: 0022-1899 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003004524A2 (en) | 2003-01-16 |
GB0116185D0 (en) | 2001-08-22 |
AU2002317946A1 (en) | 2003-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1757606E (en) | Xanthinderivatives for use as medical agents and the preparation thereof | |
HK1061679A1 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use. | |
MXPA02007568A (en) | Physiological sample collection devices and methods of using the same. | |
HK1078266A1 (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same | |
MXPA03008739A (en) | Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours. | |
IL161352A0 (en) | Methods and compositions for targeting underglycosylated proteins across the blood brain barrier | |
AU2002308348A1 (en) | Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours | |
GB0218205D0 (en) | Human ZZAP1 protein | |
ITRM20030363A1 (en) | COMPOSITIONS INCLUDING 3THIODOTYRONIN AND PHARMACEUTICAL USE OF THEM. | |
AU2002228347A1 (en) | Malaria plasmodium antigen polypeptide SE36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen | |
IL162134A0 (en) | Human cDNAs and proteins, and uses thereof | |
WO2003000733A3 (en) | Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis | |
WO2003004524A3 (en) | Apicomplexa parasites secreted proteins | |
EP1389204A4 (en) | Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same | |
GB0217548D0 (en) | Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12 | |
WO2003023002A9 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
WO2002066513A3 (en) | Human circulating lekti fragments hf7072, hf7638 and hf14448 and use thereof | |
IL161859A0 (en) | 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use | |
AU2002340728A1 (en) | Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy | |
AU2002357666A1 (en) | 69583 and 85924, novel human protein kinase family members and uses therefor | |
AU2002322404A8 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
ZA200100355B (en) | Pharmaceutical and/or cosmetic preparation. | |
AU2002245311A1 (en) | Human protein kinase n-like polypeptide and uses thereof | |
GB0403407D0 (en) | Four human zinc-finger-containing proteins: mdz3,mdz4,mdz7 and mdz12 | |
EP1401486A4 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |